MRC Integrative Epidemiology Unit at University of Bristol, United Kingdom
Disclosure(s):
Yangbo Sun, PhD, MBBS: No relevant financial relationship(s) with ineligible companies to disclose.
Objectives: Alcohol consumption is associated with adverse cardiovascular and treatment outcomes among individuals with a diagnosis of cardiovascular disease (CVD). As a key modifiable behavioral factor, alcohol consumption patterns among people with CVD, especially during treatment, remain underexplored in the United States. This study aims to comprehensively characterize alcohol consumption patterns among US adults with CVD.
Methods: This cross-sectional study used data from May 6, 2017, to July 1, 2022, from the National Institutes of Health All of Us Research Program, a diverse US cohort and included 28154 participants who reported a CVD diagnosis and completed a lifestyle survey including questions about current alcohol consumption. Our primary measures were prevalence of current drinking and of risky drinking behaviors, including exceeding moderate drinking ( >2 drinks on a typical drinking day), and binge drinking (≥6 drinks on 1 occasion).
Results: This study included 28154 adults (mean [SD] age at baseline, 64.3 [13.2] years; 14527 women [51.6%]) with a CVD diagnosis. Overall, 20852 participants (74.4%) were current drinkers. Among current drinkers, 3122 (11.1%) exceeded moderate drinking, and 5208 (18.5%) reported binge drinking. Exceed moderate drinking and binge drinking were both associated with younger age, men, Hispanic ethnicity, lower education or ever smoked (P values ≤0.001).
Conclusions: This cross-sectional study of a diverse US cohort suggests that alcohol consumption and risky drinking behaviors were common among people with CVD diagnosis. Given the adverse treatment and cardiovascular outcomes associated with alcohol consumption, additional research and implementation studies are critical in addressing this emerging concern among CVD patients.
